Hormone Replacement Therapy Market with COVID-19 Impact Analysis, By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By Indication (Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Hormone Replacement Therapy Market size was valued at USD 20,980.32 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.
Hormone Replacement Therapy (HRT) is a medical treatment that uses synthetic or naturally produced hormones to restore hormonal balance in people who have deficits or imbalances. HRT is often used to treat symptoms associated with menopause or specific medical disorders. It may include oestrogen, progesterone, or a mixture of the two. Its goal is to reduce symptoms including hot flashes, mood swings, and bone density loss. HRT comes in a variety of forms, including tablets, patches, creams, and injections. However, its usage requires careful assessment of possible dangers and advantages, which must be addressed with healthcare specialists in order to make personalized and educated choices.
Hormone Replacement Therapy Market- Market Dynamics
- Desire to alleviate menopausal symptoms and enhance quality of life for women to propel market demand
Menopause-related discomforts such as hot flashes, mood swings, and bone health issues may have a substantial influence on everyday functioning. HRT provides an effective remedy by replacing hormone levels, lowering symptoms, and alleviating related pain. This encourages women to seek HRT as a method of regaining comfort and well-being throughout a life change. The rising emphasis on women\'s health empowerment, as well as increased understanding of HRT\'s potential advantages, contribute to the therapy\'s sustained popularity.
Hormone Replacement Therapy Market- Key Insights
- As per the analysis shared by our research analyst, the global Hormone Replacement Therapy market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2023-2030)
- The Hormone Replacement Therapy industry is projected to grow at a significant rate due to the desire to alleviate menopausal symptoms and enhance quality of life for women.
- Based on Therapy segmentation, Estrogen Hormone Replacement was predicted to show maximum market share in the year 2022
- Based on Route of Administration segmentation, Parenteral was the leading type in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Hormone Replacement Therapy Market- Segmentation Analysis:
The Global Hormone Replacement Therapy Market is segmented on the basis of Therapy, Route of Administration, Indication, and Region.
The market is divided into three categories based on Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement. The Estrogen Hormone Replacement sector dominates the market. Estrogen Hormone Replacement Therapy (HRT) remains popular owing to its success in alleviating menopausal symptoms such as hot flashes, vaginal dryness, and bone health issues. Women want Estrogen HRT to enhance their quality of life throughout menopause, which contributes to its continued popularity as a therapy choice.
The market is divided into two categories based on Route of Administration: Oral, Parenteral, and Other Routes of Administration. The Parenteral sector dominates the market and is likely to maintain its dominance during the forecast period. The demand for parenteral Hormone Replacement Therapy (HRT) remains high, particularly among those looking for quick and accurate hormone administration. Parenteral HRT, which is provided by injections or implants, provides efficient and direct absorption, making it a favored alternative for patients who want regulated hormone levels and immediate symptom relief.
Hormone Replacement Therapy Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Asia pacific dominated the market. Women in the area seek treatment from menopausal symptoms such as hot flashes and osteoporosis as the population ages and lifestyles change. Rising demand is being driven by growing knowledge of the advantages of HRT, as well as urbanisation and improved healthcare access. Cultural attitudes, poor healthcare infrastructure, and worries about possible hazards, on the other hand, may impact use. To successfully satisfy the different needs for HRT in the Asia-Pacific region, it is critical to tailor HRT choices to local preferences, handle cultural sensitivities, and provide clear information about advantages and hazards.
Hormone Replacement Therapy Market- Competitive Landscape:
Pharmaceutical behemoths such as Novartis, Pfizer, and Eli Lilly dominate the Hormone Replacement Therapy (HRT) competitive landscape with proven hormone products and vast market reach. These businesses gain from their research capacity as well as their brand reputation. Furthermore, smaller and more specialized businesses such as TherapeuticsMD and Mithra Pharmaceuticals provide specialty formulations that address particular requirements. Treatment effectiveness, safety issues, administration modalities, and patient preferences all impact market rivalry. Companies that concentrate on new, well-tolerated, and easy HRT solutions are expected to gain a competitive advantage in this developing market as demand for personalized healthcare develops.
Recent Developments:
- In June 2023, Following a voluntary recall, Pfizer Inc. reported that DUAVEE, an estrogen-based menopausal hormone treatment, is now back in stock in the United States, with better packaging. The recall was issued owing to a problem with the packaging rather than any effectiveness or safety issues with the product itself.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HORMONE REPLACEMENT THERAPY MARKET KEY PLAYERS
- Novartis Pharmaceuticals
- Pfizer Inc.
- Eli Lilly and Company
- Bayer AG
- AbbVie Inc.
- Merck & Co., Inc.
- Amgen Inc.
- TherapeuticsMD, Inc.
- Allergan plc
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals
- Mithra Pharmaceuticals
- Noven Pharmaceuticals
- Besins Healthcare
GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY
- Estrogen Hormone Replacement
- Growth Hormone Replacement
- Thyroid Hormone Replacement
- Testosterone Replacement
GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION
- Oral
- Parenteral
- Other Routes of Administration
GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION
- Menopause
- Hypothyroidism
- Growth Hormone Deficiency
- Other Indications
GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hormone Replacement Therapy Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hormone Replacement Therapy Market Snippet by Therapy
2.1.2. Hormone Replacement Therapy Market Snippet by Route of Administration
2.1.3. Hormone Replacement Therapy Market Snippet by Indication
2.1.4. Hormone Replacement Therapy Market Snippet by Country
2.1.5. Hormone Replacement Therapy Market Snippet by Region
2.2. Competitive Insights
3. Hormone Replacement Therapy Key Market Trends
3.1. Hormone Replacement Therapy Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hormone Replacement Therapy Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hormone Replacement Therapy Market Opportunities
3.4. Hormone Replacement Therapy Market Future Trends
4. Hormone Replacement Therapy Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hormone Replacement Therapy Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Hormone Replacement Therapy Market Landscape
6.1. Hormone Replacement Therapy Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hormone Replacement Therapy Market – By Therapy
7.1. Overview
7.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
7.1.2. Estrogen Hormone Replacement
7.1.3. Growth Hormone Replacement
7.1.4. Thyroid Hormone Replacement
7.1.5. Testosterone Replacement
8. Hormone Replacement Therapy Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
8.1.2. Oral
8.1.3. Parenteral
8.1.4. Other Routes of Administration
9. Hormone Replacement Therapy Market – By Indication
9.1. Overview
9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
9.1.2. Menopause
9.1.3. Hypothyroidism
9.1.4. Growth Hormone Deficiency
9.1.5. Other Indications
10. Hormone Replacement Therapy Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Hormone Replacement Therapy Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Hormone Replacement Therapy Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Hormone Replacement Therapy Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Hormone Replacement Therapy Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Hormone Replacement Therapy Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Hormone Replacement Therapy Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Novartis Pharmaceuticals
11.2.2. Pfizer Inc.
11.2.3. Eli Lilly and Company
11.2.4. Bayer AG
11.2.5. AbbVie Inc.
11.2.6. Merck & Co., Inc.
11.2.7. Amgen Inc.
11.2.8. TherapeuticsMD, Inc.
11.2.9. Allergan plc
11.2.10. Mylan N.V.
11.2.11. Teva Pharmaceutical Industries Ltd.
11.2.12. Glenmark Pharmaceuticals
11.2.13. Mithra Pharmaceuticals
11.2.14. Noven Pharmaceuticals
11.2.15. Besins Healthcare
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
